Harnessing monocyte-derived dendritic cells for evaluating T cell response by mixed leukocyte reaction
Open Access
- 30 June 2025
- journal article
- Published by Open Exploration Publishing in Exploration of Immunology
- Vol. 5, 1003201
Abstract
The mixed leukocyte reaction (MLR) is a pivotal in vitro assay for evaluating T-cell responses stimulated by allogeneic antigen-presenting cells (APCs). Dendritic cells (DCs) are the most efficient stimulatory cells. However, the scarcity of circulating DCs in peripheral blood limits their isolation for research or clinical use. In contrast, monocytes, which are abundant and easily accessible, can be differentiated into monocyte-derived DCs (moDCs) in vitro and have emerged as the most practical and efficient stimulatory cells for MLR due to their accessibility and robust allostimulatory capabilities. This review aims to describe the scientific rationale and evidence for using moDCs in MLR assays to assess T-cell alloreactivity. Its methodology outlines the protocols for experimental, preclinical, and biosafety assays that have demonstrated the practicality of moDCs in evaluating and quantifying the alloresponse of naïve and memory CD4+ and CD8+ T cells, as well as the effects of immunomodulatory factors, immune monitoring, and tolerogenic strategies in the context of transplantation. Additionally, it illustrates how moDC-mediated MLRs have provided critical insights into understanding alloimmunity processes and antigen-specific T-cell responses in cancer immunotherapy, autoimmune diseases, and vaccine development, with potential implications for personalized medicine and immunotherapy optimization. In conclusion, despite ongoing challenges such as standardization and scalability in massive cell production, the current understanding and reproducible results of moDC applications in MLRs highlight their potential to develop innovative strategies focused on immune monitoring.Keywords
This publication has 117 references indexed in Scilit:
- The immune system2023
- Toll-like receptor 2 deficiency promotes the generation of alloreactive Th17 cells after cardiac transplantation in miceCellular Immunology, 2019
- Rejection-Resistant Off-the-Shelf T Cells for Adoptive Cell TherapyTransplantation and Cellular Therapy, 2019
- A Dual ICOS/CD28 Antagonist ICOSL Variant Ig Domain (vIgD) Potently Suppresses Human Mixed Lymphocyte Reactions and Human/NSG Mouse Xenograft Graft vs. Host Disease (GvHD)Transplantation and Cellular Therapy, 2018
- Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host DiseaseStem Cells, 2016
- Isolation and Generation of Human Dendritic CellsCurrent Protocols in Immunology, 2012
- Tolerogenic dendritic cells in autoimmune diseasesAutoimmunity Reviews, 2010
- IL-10/TGF-β-Treated Dendritic Cells, Pulsed with Insulin, Specifically Reduce the Response to Insulin of CD4+ Effector/Memory T Cells from Type 1 Diabetic IndividualsJournal of Clinical Immunology, 2010
- Dendritic cells derived from metastatic cancer patients vaccinated with allogeneic dendritic cell?autologous tumor cell hybrids express more CD86 and induce higher levels of interferon-gamma in mixed lymphocyte reactionsCancer Immunology, Immunotherapy, 2004
- Immunotherapy using autologous monocyte‐derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantationJournal of Clinical Apheresis, 2004